Kintz Samuel
SEC CIK 1967168 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Pres, CEO, Dir | 890.4K | — | $7.44M | 45 | 2023-02-23 | 2025-11-17 |
Most active insiders at ELVN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| 2 | Derynck Mika K | Dir | — | $9.56M |
| 3 | Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| 4 | Lyssikatos Joseph P | CSO | — | $4.88M |
| 5 | Patel Anish | COO | — | $1.74M |
| 6 | Hohl Benjamin | CFO | — | $1.60M |
| 7 | Kunkel Lori Anne | Dir | — | $850.3K |
| 8 | Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| 9 | Heyman Richard A. | Dir | — | $413.4K |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-11-19 | 2025-11-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.82 | -12.5K | 890.4K | -1% | -$272.8K |
| I | 2025-10-21 | 2025-10-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.33 | -12.5K | 902.9K | -1% | -$266.6K |
| I | 2025-09-30 | 2025-09-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.06 | -3,700 | 915.4K | -0.4% | -$74.2K |
| I | 2025-09-25 | 2025-09-23 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.03 | -2,800 | 919.1K | -0.3% | -$56.1K |
| MI | 2025-09-19 | 2025-09-17+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $19.28 | -6,000 | 922.9K | -0.6% | -$115.7K |
| AI | 2025-08-21 | 2025-08-20 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.00 | -1,517 | 927.9K | -0.2% | -$30.3K |
| MI | 2025-08-20 | 2025-08-18+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.02 | -11.0K | 929.4K | -1% | -$219.9K |
| MI | 2025-07-21 | 2025-07-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.52 | -12.5K | 940.4K | -1% | -$281.5K |
| MI | 2025-06-18 | 2025-06-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.19 | -12.5K | 952.9K | -1% | -$277.3K |
| I | 2025-06-05 | 2025-06-03 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.05 | -7,500 | 965.4K | -0.8% | -$150.4K |
| I | 2025-05-21 | 2025-05-19 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $16.49 | -5,000 | 972.9K | -0.5% | -$82.4K |
| MI | 2025-05-05 | 2025-05-01+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.06 | -7,500 | 980.1K | -0.8% | -$150.4K |
| I | 2025-04-21 | 2025-04-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $16.42 | -5,000 | 985.4K | -0.5% | -$82.1K |
| I | 2025-03-19 | 2025-03-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.83 | -12.5K | 990.4K | -1% | -$260.4K |
| I | 2024-10-22 | 2024-10-18 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $30.00 | -924 | 1.00M | -0.1% | -$27.7K |
| MI | 2024-10-10 | 2024-10-08+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $28.06 | -30.0K | 1.01M | -3% | -$841.2K |
| MI | 2024-10-08 | 2024-10-04+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.51 | -14.9K | 1.03M | -1% | -$410.9K |
| I | 2024-10-03 | 2024-10-01 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.54 | -526 | 1.05M | -0.1% | -$14.5K |
| I | 2024-08-28 | 2024-08-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.89 | -12.0K | 1.05M | -1% | -$274.7K |
| I | 2024-08-02 | 2024-07-31 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.56 | -2,270 | 1.06M | -0.2% | -$62.6K |
| MI | 2024-07-29 | 2024-07-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $24.92 | -12.0K | 1.06M | -1% | -$299.1K |
| MI | 2024-06-27 | 2024-06-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.66 | -12.0K | 1.08M | -1% | -$259.9K |
| D | 2024-05-30 | 2024-05-28 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-05-30 | 2024-05-28 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $23.18 | -12.0K | 0 | -100% | -$278.2K |
| D | 2024-04-29 | 2024-04-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $16.89 | -12.0K | 0 | -100% | -$202.7K |
| D | 2024-04-29 | 2024-04-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +47.7K | 47.7K | New | +$53.4K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $25.04 | -47.7K | 0 | -100% | -$1.19M |
| DM | 2024-03-27 | 2024-03-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $17.56 | -12.0K | 0 | -100% | -$210.7K |
| D | 2024-03-27 | 2024-03-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-02-28 | 2024-02-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $16.89 | -12.0K | 4,376 | -73% | -$202.7K |
| D | 2024-02-28 | 2024-02-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-01-29 | 2024-01-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $15.69 | -12.0K | 0 | -100% | -$188.3K |
| D | 2024-01-29 | 2024-01-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2023-12-28 | 2023-12-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $14.64 | -12.0K | 0 | -100% | -$175.7K |
| D | 2023-12-28 | 2023-12-26 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +8,195 | 8,175 | New | +$9,178 |
| DM | 2023-12-26 | 2023-12-21+ | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.05 | -8,195 | 0 | -100% | -$106.9K |
| D | 2023-12-21 | 2023-12-20 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.01 | -7,779 | 0 | -100% | -$101.2K |
| D | 2023-12-21 | 2023-12-20 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +7,779 | 7,779 | New | +$8,712 |
| D | 2023-11-06 | 2023-11-03 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.08 | -8,026 | 0 | -100% | -$105.0K |
| D | 2023-11-06 | 2023-11-03 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +8,026 | 8,026 | New | +$8,989 |
| D | 2023-09-26 | 2023-09-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | S - Sale+OE | $13.81 | -12.0K | 0 | -100% | -$165.7K |
| D | 2023-09-26 | 2023-09-25 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DMI | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO, Dir | A - Grant | — | +1.26M | 1.09M | New | — |
Purchase Sale Sale after option exercise All abbreviations